In today’s recent session, 21.19 million shares of the Bionano Genomics Inc (NASDAQ:BNGO) have been traded, and its beta is 2.23. Most recently the company’s share price was $0.30, and it changed around $0.01 or 4.93% from the last close, which brings the market valuation of the company to $30.62M. BNGO at last check was trading at a discount to its 52-week high of $2.16, offering almost -620.0% off that amount. The share price’s 52-week low was $0.19, which indicates that the recent value has risen by an impressive 36.67% since then. We note from Bionano Genomics Inc’s average daily trading volume that its 10-day average is 7.03 million shares, with the 3-month average coming to 3.61 million.
Bionano Genomics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 4 recommended BNGO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Bionano Genomics Inc is expected to report earnings per share of -0.14 for the current quarter.
Bionano Genomics Inc (NASDAQ:BNGO) trade information
Instantly BNGO has been showing a green trend so far today with a performance of 4.93% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.3600 on recent trading dayincreased the stock’s daily price by 16.67%. The company’s shares are currently down -84.12% year-to-date, but still up 48.83% over the last five days. On the other hand, Bionano Genomics Inc (NASDAQ:BNGO) is 17.45% up in the 30-day period. We can see from the shorts that 9.83 million shares have been sold at a short interest cover period of 3.81 day(s).
The consensus price target as assigned by Wall Street analysts is $1, which translates to bulls needing to increase their stock price by 70.0% from its current value. Analyst projections state that BNGO is forecast to be at a low of $1 and a high of $1.
Bionano Genomics Inc (BNGO) estimates and forecasts
Bionano Genomics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -47.35 percent over the past six months and at a 60.75% annual growth rate that is well above the industry average of 16.70%. The year-over-year growth rate is expected to be -19.97%, down from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 6.3M in revenue for the current quarter. 4 analysts expect Bionano Genomics Inc to make 8.15M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 10.72M and 8.77M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -41.24%. Forecasts for the next quarter put sales growth at -7.05%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 23.59%.
BNGO Dividends
Bionano Genomics Inc’s next quarterly earnings report is expected to be released in January.
Bionano Genomics Inc (NASDAQ:BNGO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.15% of Bionano Genomics Inc shares, and 12.81% of them are in the hands of institutional investors. The stock currently has a share float of 12.83%.
